Drug intelligence / Profile preview

cultured epidermal autografts

Development stage
Unknown
Lead developer
Vericel
Modality
Stem Cell Therapies → Cell Therapies
Administration
Topical
01

Overview

Cultured epidermal autografts (CEA) are an autologous cell therapy involving the laboratory expansion of a patient's own keratinocytes into sheets of stratified squamous epithelium. This technology is primarily used as a permanent skin replacement for patients with deep dermal or full-thickness burns covering a large percentage of the total body surface area (typically >30%), where available donor sites for traditional split-thickness skin grafts are insufficient. The process begins with a small full-thickness skin biopsy, from which keratinocytes are harvested and expanded, often using a feeder layer of irradiated fibroblasts. Once the sheets reach sufficient maturity, they are transplanted back to the patient's wound bed. Beyond severe burns, CEA has been investigated and approved in certain regions for treating giant congenital melanocytic nevi and epidermolysis bullosa, and it is under study for conditions like stable vitiligo and various forms of ichthyosis.

Brand names
EpicelJACE
Other names
CEAautologous cultured epidermal graftscultured keratinocyte graftsautologous cultured epitheliumcultured epithelial autografts

Beyond the preview

Go deeper on cultured epidermal autografts.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cultured epidermal autografts.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call